Thierry Van Nieuwenhove Appointed as CEO of Quotient Sciences
UK-headquartered drug development and manufacturing organization (CDMO) Quotient Sciences has appointed Thierry Van Nieuwenhove as its new CEO, effective Oct. 16, 2023. He succeeds Mark Egerton who retires after 18 years in this role.
As part of the leadership transition, the company also appointed Wayne Hewett as non-executive chairman.
Van Nieuwenhove, who has over 23 years of professional experience in the pharma/CDMO industry, joins Quotient from ABL where he was CEO for the last two years. Prior to this, he held various leadership roles in the CDMO industry, including Novasep, Lonza, and Minakem.
Hewett has more than three decades of board and leadership experience. He is currently chairman of CDMO Cambrex and serves on the board of directors of The Home Depot, Wells Fargo, UPS and Lytx, as well as a senior adviser to Permira.
Thierry Van Nieuwenhove, CEO, Quotient Sciences. Source: Quotient Sciences
